Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.
暂无分享,去创建一个
A. Minguela | S. Llorente | J. A. Campillo | M. Muro | M. Moya-Quiles | G. Salgado | R. López-Hernández | F. Boix | L. Jimeno | Manuela López | A. Bosch | J. Diaz | María J González-Soriano | Noelia Perez-Lopez | María R Alvarez-López | M. Álvarez-López
[1] M. González-Escribano,et al. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] R. Duquesnoy. The antibody response to an HLA mismatch: a model for nonself–self discrimination in relation to HLA epitope immunogenicity , 2012, International journal of immunogenetics.
[3] A. Amoroso,et al. Brief report: Why did two patients who type for HLA-B13 have antibodies that react with all Bw4 antigens except HLA-B13? , 2011, Transplant immunology.
[4] R. Duquesnoy. Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications. , 2011, Tissue antigens.
[5] P. Archdeacon,et al. Summary of FDA Antibody‐Mediated Rejection Workshop , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[6] D. Roelen,et al. Challenging the golden standard in defining donor-specific antibodies: does the solid phase assay meet the expectations? , 2011, Tissue antigens.
[7] F. Claas,et al. Human Monoclonal Antibody Reactivity With Human Leukocyte Antigen Class I Epitopes Defined by Pairs of Mismatched Eplets and Self-Eplets , 2010, Transplantation.
[8] A. Minguela,et al. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation. , 2010, Human immunology.
[9] V. D’Agati,et al. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation. , 2008, Transplant immunology.
[10] M. Christiaans,et al. Luminex donor-specific crossmatches. , 2008, Tissue antigens.
[11] T. Larson,et al. Transplant Glomerulopathy: Subclinical Incidence and Association with Alloantibody , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] C. Haisch,et al. Extremely High Association Between Appearance of HLA Antibodies and Failure of Kidney Grafts in a Five‐Year Longitudinal Study , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] P. Terasaki,et al. The Importance of Anti‐HLA‐Specific Antibody Strength in Monitoring Kidney Transplant Patients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] Medhat Askar,et al. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. , 2007, Human immunology.
[15] A. Minguela,et al. Pre-formed donor-specific alloantibodies (DSA) detected only by luminex technology using HLA-coated microspheres and causing acute humoral rejection and kidney graft dysfunction. , 2006, Clinical transplants.
[16] A. Minguela,et al. Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre. , 2005, Transplant immunology.
[17] S. Llorente,et al. Acute vascular rejection mediated by HLA antibodies in a cadaveric kidney recipient: discrepancies between FlowPRA, ELISA and CDC vs luminex screening. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[18] D. Roelen,et al. THE NUMBER OF AMINO ACID TRIPLET DIFFERENCES BETWEEN PATIENT AND DONOR IS PREDICTIVE FOR THE ANTIBODY REACTIVITY AGAINST MISMATCHED HUMAN LEUKOCYTE ANTIGENS1 , 2004, Transplantation.
[19] P. Terasaki,et al. Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] D. DeLuca,et al. HistoCheck: rating of HLA class I and II mismatches by an internet-based software tool , 2004, Bone Marrow Transplantation.
[21] Rene J. Duquesnoy,et al. HLA MATCHMAKER: A MOLECULARLY BASED ALGORITHM FOR HISTOCOMPATIBILITY DETERMINATION , 2003 .